• In recent days, Mirion Technologies issued 2026 adjusted EPS guidance that came in below market expectations, following mixed fourth‑quarter results and cautious forward commentary.
• At the same time, institutional investors have highlighted Mirion’s entrenched presence in global nuclear and radiation monitoring markets and its growing backlog tied to digital transformation initiatives, underscoring a contrast between near‑term caution and longer‑term business strengths.
• We’ll now examine how Mirion’s lower‑than‑expected 2026 EPS guidance and cautious outlook may influence the company’s broader investment narrative.

Find 48 companies with promising cash flow potential yet trading below their fair value.

Mirion Technologies Investment Narrative Recap

To own Mirion, you need to be comfortable with a tightly regulated, niche business that sits at the center of nuclear and medical radiation safety, where contract visibility and recurring revenue matter as much as quarterly beats. The reset in 2026 EPS guidance appears more about tempering near term expectations than changing the core thesis, but it does shine a brighter light on execution risk around integrating acquisitions and scaling digital offerings as the key short term swing factor.

The most relevant recent development here is Mirion’s 2026 guidance for roughly 22% to 24% revenue growth, which now sits alongside lower than expected adjusted EPS. That pairing brings the quality of growth into focus, especially margin delivery and cost control, at the very moment investors are treating the expanding backlog and digital transformation projects as core catalysts for the story.

Yet against this backdrop, investors should be aware of how dependent Mirion still is on nuclear sector spending and what happens if...

Mirion Technologies' narrative projects $1.1 billion revenue and $105.2 million earnings by 2028.

Uncover how Mirion Technologies' forecasts yield a $29.30 fair value, a 57% upside to its current price.

Exploring Other Perspectives

Four Simply Wall St Community valuations for Mirion span roughly US$17 to US$29 per share, showing how far apart individual views can be. Set against EPS guidance that underwhelmed the market, this spread underlines why you should compare several viewpoints before forming a view on Mirion’s earnings power and resilience.

Explore 4 other fair value estimates on Mirion Technologies - why the stock might be worth 7% less than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Mirion Technologies research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Mirion Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Mirion Technologies' overall financial health at a glance.

Searching For A Fresh Perspective?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
• Invest in the nuclear renaissance through our list of 87 elite nuclear energy infrastructure plays powering the global AI revolution.
• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.